IOS IONOS Group SE
IONOS Group SE, together with its subsidiaries, provides web presence and productivity, and cloud solutions for companies in Germany, the United States, the United Kingdom, Spain, France, Poland, and Austria. The company provides solutions for online presence, including domain registration, web hosting, website builders with artificial intelligence support, and dedicated servers; productivity products, such as e-commerce, email, and marketing applications; search engine optimization, business applications or storage, and security solutions; and public and private cloud solutions with a wide range of services in the area of Infrastructure-as-a-Service (IaaS), Platform-as-a-Service (PaaS), and Software-as-a-Service (SaaS) under the IONOS, STRATO, arsys, fasthosts, home.pl, World4You, United Domains, and InterNetX brands. The company was formerly known as IONOS TopCo SE and changed its name to IONOS Group SE in December 2022. The company was founded in 1988 and is based in Montabaur, Germany. IONOS Group SE is a subsidiary of United Internet AG.…
Industry Peers
Information Technology ServicesKey Statistics
About IONOS Group (ETR: IOS)
›
IONOS Group (ETR: IOS) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Information Technology Services industry, part of the Technology sector, and reports about 4,021 employees.
The shares were at 34.70 EUR on 19 November 2026, down 4.1% over 52 weeks. Its 52-week range is 20.90 EUR to 42.45 EUR: the price is 18.3% below the high and 66.0% above the low.
At a market capitalisation of 4.67B EUR, it trades at 19.6 times trailing earnings and 15.5 times forward earnings. The median trailing P/E of its 20 largest Information Technology Services peers is 15.2, a premium of 29% for IOS.
IONOS Group reports return on equity of 76.9%, an operating margin of 27.5% and revenue up 9.0% year over year.
Its debt exceeds its cash by 841.89M EUR, a debt-to-equity ratio of 3.02. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 12 analysts cover the stock, with an average rating of Buy; their mean price target of 38.40 EUR is 10.7% above the current price. The next earnings report is expected on 18 March 2027.